CT
REGN icon

Caldwell Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Caldwell Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Hold
28
– – ﹤0.01% 586
2025
Q4 		$21.6K Sell
28
-70
-71% -$47.5K ﹤0.01% 572
2025
Q3 		$55.1K Hold
98
– – 0.01% 461
2025
Q2 		$51.5K Sell
98
-15
-13% -$8.37K 0.01% 463
2025
Q1 		$71.7K Buy
113
+85
+304% +$58.5K 0.01% 410
2024
Q4 		$19.9K Hold
28
– – ﹤0.01% 550
2024
Q3 		$29.4K Hold
28
– – ﹤0.01% 511
2024
Q2 		$29.4K Hold
28
– – ﹤0.01% 506
2024
Q1 		$26.9K Hold
28
– – ﹤0.01% 522
2023
Q4 		$24.6K Hold
28
– – ﹤0.01% 523
2023
Q3 		$23K Sell
28
-22
-44% -$17.3K ﹤0.01% 527
2023
Q2 		$35.9K Buy
50
+5
+11% +$3.85K ﹤0.01% 493
2023
Q1 		$37K Sell
45
-1
-2% -$754 0.01% 479
2022
Q4 		$33.2K Buy
46
+28
+156% +$20.7K ﹤0.01% 480
2022
Q3 		$12.4K Hold
18
– – ﹤0.01% 580
2022
Q2 		$10.6K Sell
18
-3
-14% -$1.95K ﹤0.01% 622
2022
Q1 		$14.7K Hold
21
– – ﹤0.01% 603
2021
Q4 		$13.3K Hold
21
– – ﹤0.01% 612
2021
Q3 		$12.7K Hold
21
– – ﹤0.01% 616
2021
Q2 		$11.7K Buy
21
+3
+17% +$1.52K ﹤0.01% 632
2021
Q1 		$8.52K Hold
18
– – ﹤0.01% 644
2020
Q4 		$8.7K Hold
18
– – ﹤0.01% 633
2020
Q3 		$10.1K Hold
18
– – ﹤0.01% 611
2020
Q2 		$11.2K Buy
+18
New +$10.2K ﹤0.01% 621

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Caldwell Trust's REGN Position: Q1 2026 in Review

Caldwell Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 28 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #586.

Caldwell Trust first reported a position in REGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $71.7K in Q1 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Caldwell Trust held 28 shares of Regeneron Pharmaceuticals worth $21.6K as of Q1 2026.
  • Caldwell Trust left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #586 holding.
  • Caldwell Trust first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Caldwell Trust's Regeneron Pharmaceuticals position peaked at $71.7K in Q1 2025.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.